Cholinesterase Inhibitors for Cognitive Symptoms

Type: drug

Status: FDA Approved (for Alzheimer's, used off-label for LBD)

Developer: Multiple pharmaceutical companies

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026